People who inject
drugs represent approximately 90% of newly acquired hepatitis C infections.
Clinicians in drug and alcohol settings play an important role in improving the
health outcomes of people living with hepatitis C and can reduce a patient’s
risk of developing advanced liver disease through early diagnosis, appropriate
management of co-morbidities and treatment with new, curative, Direct Acting
Antiviral medication (DAAs).
This course is designed to strengthen the
capacity of clinical staff working in drug and alcohol settings, or working
with people who inject drugs, to effectively test for, treat and manage
hepatitis C. This highly interactive course is available for GPs and other
clinicians able to prescribe. The online learning and face-face workshop will
give you the skills to confidently prescribe the new DAAs.
People who inject drugs (PWID) account for the majority of new (90%) and existing (65-70%) cases of HCV in many high- and middle-income countries. Drug and alcohol settings and GP practices working with PWID are logical venues for expanding HCV care, given the large burden of HCV infection and an existing framework for the provision of quality patient care to PWID. This Education Program is designed to enable GPs to demonstrate their competency in management and treatment of hepatitis C. GPs, who successfully complete all components of this course including the online assessment, will have the confidence, knowledge and clinical decision-making skills to effectively test for, treat and manage HCV infection. By providing participants with tailored testing and management protocols based on local referral pathways and through engaging local expert speakers, the Program will also enhance linkages between primary health and specialist viral hepatitis services.
Please download the course flyer here for more information
Dr Jacqui Richmond has had a long interest in viral hepatitis working in education, research, policy development and nursing. She is currently coordinating the education and training program for the Eliminate Hep C partnership at Burnet Institute, a clinical nurse consultant at Melbourne Health and is a research fellow at La Trobe University.
Dr Paul Grinzi has incorporated an interest in addiction medicine within his general practice, which has included a number of patients with Hepatitis C infection. Paul has completed training to be an S100 Hep C prescriber and is also part of the Royal College of General Practitioners' Special Interest Addiction Network, and Chair of the RACGP Victorian Drug and Alcohol committee.
Dr Sern Wei Yeoh is a gastroenterologist with a wide interest in many conditions including viral and autoimmune hepatitis.
Dr John O'Donoghue is a GP with interest in addiction and Hep C. He has been treating addiction for over 20 years and Hep C for over 10 years. Former medical director First Step Program, life member of the Windana Society.
Course Venue: Quest
Dandenong Central, 2-10 Walker Street, Dandenong VIC
Course Date: Sunday 30th April 2017
Course Time: 8.30am – 5.00pm
Registration Close: 30th April 2017Learning Method: Presentation; Group Discussion
Target Audience: GP’s, nurses and primary health care
practitioners working in the field of addiction medicine and/or Blood borne